Nanobac Pharmaceuticals, Incorporated (NNBP)
OTCMKTS · Delayed Price · Currency is USD
0.0000
0.00 (0.00%)
At close: Jan 12, 2026
Nanobac Pharmaceuticals Market Cap
Nanobac Pharmaceuticals has a market cap or net worth of $250 as of January 23, 2026. Its market cap has decreased by -99.83% in one year.
Market Cap
250.00
Enterprise Value
n/a
Revenue
17.62K
Ranking
n/a
PE Ratio
n/a
Stock Price
$0.00
Market Cap Chart
Since June 16, 2003, Nanobac Pharmaceuticals's market cap has decreased from 18.83M to 250.00, a decrease of -100.00%. That is a compound annual growth rate of -39.17%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 12, 2026 | 250.00 | - |
| Dec 31, 2025 | 250.00 | - |
| Dec 23, 2024 | 250.00 | - |
| Dec 21, 2023 | 250.00 | - |
| Dec 16, 2022 | 250.00 | -99.75% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| RegeneRx Biopharmaceuticals | 453.00 |
| Eloxx Pharmaceuticals | 330.00 |
| Nabriva Therapeutics | 323.00 |
| Predictive Technology Group | 317.00 |
| Alzex Neuropharma | 301.00 |
| Spencer Pharmaceutical | 271.00 |
| NanoLogix | 163.00 |
| Regenicin | 153.00 |